A Study for Type 2 Diabetic Patients
NCT00548808
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
426
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Insulin lispro low mixture
DRUG:
Insulin glargine
DRUG:
Insulin lispro
Sponsor
Eli Lilly and Company